Shashank R. Joshi

Specialty: Medicine

Location: Global

Tier: UNRANKED

H-Index: 0

Years Active: 0

Hospital Affiliations

• Metabolic syndrome - Member

Key Publications

1. "A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings." - J Diabetes Sci Technol (2023)
2. "Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis." - Diabetes Metab Syndr (2023)
3. "Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV." - J Clin Lipidol (2024)
4. "Think thyroid." - J Assoc Physicians India (2011)
5. "Global multi-societies endorsement of the MAFLD definition." - Ann Hepatol (2024)

Knowledge Graph Relationships

Shashank R. Joshi is a Medicine specialist affiliated with Metabolic syndrome. Authored 5 scholarly articles.